JPH0827005A - Antimicrobial agent - Google Patents
Antimicrobial agentInfo
- Publication number
- JPH0827005A JPH0827005A JP18193894A JP18193894A JPH0827005A JP H0827005 A JPH0827005 A JP H0827005A JP 18193894 A JP18193894 A JP 18193894A JP 18193894 A JP18193894 A JP 18193894A JP H0827005 A JPH0827005 A JP H0827005A
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial agent
- agent
- bacteria
- antimicrobial agent
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004599 antimicrobial Substances 0.000 title abstract 6
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960001553 phloroglucinol Drugs 0.000 claims abstract description 7
- 229940121375 antifungal agent Drugs 0.000 claims abstract description 6
- 239000003429 antifungal agent Substances 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 235000013305 food Nutrition 0.000 claims abstract description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 18
- 208000002925 dental caries Diseases 0.000 claims description 7
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 claims description 5
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 4
- 230000003239 periodontal effect Effects 0.000 claims description 4
- 244000052769 pathogen Species 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 16
- 229930014626 natural product Natural products 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 3
- 230000000845 anti-microbial effect Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 150000002894 organic compounds Chemical class 0.000 abstract description 2
- 230000003071 parasitic effect Effects 0.000 abstract description 2
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 9
- 235000005979 Citrus limon Nutrition 0.000 description 7
- 244000131522 Citrus pyriformis Species 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 241000233866 Fungi Species 0.000 description 5
- 235000020971 citrus fruits Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 235000005976 Citrus sinensis Nutrition 0.000 description 4
- 240000002319 Citrus sinensis Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 240000000560 Citrus x paradisi Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 208000028169 periodontal disease Diseases 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000009422 growth inhibiting effect Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 240000000968 Parkia biglobosa Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000122123 Penicillium italicum Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 241000347168 Porphyromonas gingivalis 381 Species 0.000 description 1
- 241001135221 Prevotella intermedia Species 0.000 description 1
- 241000185992 Rhizobium viscosum Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- -1 glycerin fatty acid ester Chemical class 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 235000014058 juice drink Nutrition 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 150000003000 phloroglucinols Chemical class 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000007218 ym medium Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、抗菌剤に関するもので
あり、更に詳細には、天然有機化合物を有効成分とする
安全性の高いすぐれた抗菌剤に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibacterial agent, and more particularly to a highly safe antibacterial agent containing a natural organic compound as an active ingredient.
【0002】[0002]
【従来の技術】従来、天然物、特に柑橘類の果皮に由来
し、水に溶けやすく、無味、無臭であり、熱に安定な、
抗菌力にすぐれ且つ安全性の高い、フロログルシノール
系抗菌性物質については、これを単離、精製し、構造決
定に成功した例は知られていない。2. Description of the Related Art Conventionally, it is derived from natural products, especially citrus peels, is easily soluble in water, has no taste and odor, and is stable to heat.
As for the phloroglucinol-based antibacterial substance having excellent antibacterial activity and high safety, no examples have been known in which the structure was successfully isolated by isolating and purifying it.
【0003】一方、β−D−グルコピラノキシ フロロ
グルシノール(以下、LE−Vという場合もある)が、
微生物(例えば虫歯菌、歯周病菌や植物に寄生するカビ
類)に対してすぐれた抗菌性を有することについては、
特許はもとより、他の研究報告もなされていない。On the other hand, β-D-glucopyranoxy phloroglucinol (hereinafter sometimes referred to as LE-V) is
For having excellent antibacterial properties against microorganisms (eg, caries, periodontal bacteria and fungi parasitic on plants),
Neither patents nor other research reports have been made.
【0004】[0004]
【発明が解決しようとする課題】現在のところ、やむを
得ず抗菌剤としては化学合成品が使用されているが、人
体や環境に対する安全性の面で問題がある。そこで、当
業界においては、安全性が高く、取扱いやすく、しかも
適用範囲も広いすぐれた抗菌剤の開発が待望されてい
る。At present, a chemically synthesized product is unavoidably used as an antibacterial agent, but there is a problem in terms of safety for human body and environment. Therefore, in the industry, development of an excellent antibacterial agent which is highly safe, easy to handle, and has a wide application range is desired.
【0005】[0005]
【課題を解決するための手段】本発明は、上記した業界
のニーズに応えるためになされたものであって、安全性
重視の面から、天然物に着目した。The present invention has been made in order to meet the needs of the above-mentioned industry, and attention was paid to natural products in terms of safety.
【0006】そこで本発明者らは、天然物由来の抗菌性
物質を求めて鋭意研究したところ、レモン、グレープフ
ルーツ、バレンシアオレンジ、ネーブルオレンジなどの
柑橘類の果皮に抗菌性物質が含まれることを確認したの
である。そして、抗菌性物質を分離、精製するのに成功
しただけでなく、精製物質(LE−V)についてその構
造決定にも成功し、そして更にこの精製物質のすぐれた
抗菌性も確認し、遂に本発明の完成に至ったものであ
る。[0006] Therefore, the inventors of the present invention have conducted extensive studies in search of an antibacterial substance derived from a natural product, and have confirmed that the peel of citrus fruits such as lemon, grapefruit, valencia orange and navel orange contains the antibacterial substance. Of. And, not only succeeded in separating and purifying the antibacterial substance, but also succeeding in determining the structure of the purified substance (LE-V), and further confirming the excellent antibacterial property of this purified substance, The invention was completed.
【0007】すなわち本発明は、LE−Vを有効成分と
する抗菌剤に関するものである。LE−V物質は、柑橘
類の果皮由来の天然物質であって、フロログルシノール
誘導体であり、構造決定の結果、β−D−グルコピラノ
キシ フロログルシノール(β−D−glucopyranoxy ph
loroglucinol)と同定された。That is, the present invention relates to an antibacterial agent containing LE-V as an active ingredient. The LE-V substance is a natural substance derived from citrus peel and is a phloroglucinol derivative, and as a result of the structure determination, β-D-glucopyranoxy phloroglucinol (β-D-glucopyranoxy ph
loroglucinol) was identified.
【0008】LE−Vは、レモン、グレープフルーツ、
バレンシアオレンジ、ネーブルオレンジなどの柑橘果実
の搾り粕、果皮や果汁に存在し、これらから抽出、精製
できる。抽出溶媒としては、水、熱水、アルカリ水、酸
性水のような溶媒や、メタノール、エタノール、アセト
ンのような有機溶媒でも抽出できる。そして、粗精製の
状態でも、LE−V成分が十分量あれば抗微生物効果が
発揮される。LE−V物質は、安全性が高く、卓越した
抗菌作用を示すだけでなく、その抗菌スペクトルが広範
なために各種の抗菌剤として広く使用できる。そのう
え、水に溶けやすく、無味、無臭であり、熱に安定であ
るので、きわめて使いやすく、きわめて広範囲な用途に
利用することができる。LE-V is lemon, grapefruit,
It is present in squeezed lees of citrus fruits such as Valencia orange and navel orange, as well as in the peel and juice, and can be extracted and purified from these. As the extraction solvent, a solvent such as water, hot water, alkaline water or acidic water, or an organic solvent such as methanol, ethanol or acetone can be used for extraction. Even in the crudely purified state, the antimicrobial effect is exhibited if the LE-V component is in a sufficient amount. The LE-V substance is not only highly safe and has an excellent antibacterial action, but also has a broad antibacterial spectrum, and thus can be widely used as various antibacterial agents. Moreover, it is easily soluble in water, tasteless, odorless, and stable to heat, so it is extremely easy to use and can be used in a very wide range of applications.
【0009】例えばLE−V物質は、次のような用途に
広く利用できる。飲食品に直接ないし関接的に添加し
て、日持ち向上ないし、抗菌剤としての使用;虫歯菌、
歯周病原菌に対する抗菌剤(例えば、直接患部に適用す
る薬剤、口中洗浄剤、うがい薬、歯磨きとしての使
用);抗カビ剤としての使用;果実や野菜等青果物の貯
蔵、輸送時の抗カビ剤(例えば、塗布剤、ワックス剤と
して、ポストハーベスト農薬の代替物としての使用)。
以下、本発明の実施例について述べる。For example, the LE-V substance can be widely used for the following purposes. Adds directly or indirectly to food and drink to improve shelf life or use as an antibacterial agent;
Antibacterial agents against periodontal pathogens (for example, drugs applied directly to the affected area, mouthwash, mouthwash, and toothpaste); antifungal agents; antifungal agents during storage and transportation of fruits and vegetables (For example, as a coating agent, a wax agent, and a substitute for a post-harvest pesticide).
Examples of the present invention will be described below.
【0010】[0010]
【実施例1】ミキサーで粉砕したレモン搾り粕の果皮
を、エタノールに37℃、3日間放置して抽出を行っ
た。これを、エバポレーターで減圧蒸留してエタノール
を除去した。これを水にとかし、分液ロートを用いて液
−液溶媒分画を行った。Example 1 The peel of lemon squeezed lees crushed with a mixer was allowed to stand in ethanol at 37 ° C. for 3 days for extraction. This was distilled under reduced pressure with an evaporator to remove ethanol. This was dissolved in water, and liquid-liquid solvent fractionation was performed using a separating funnel.
【0011】液−液溶媒分画は、溶媒として、ヘキサ
ン、クロロホルム、酢酸エチル、水飽和ブタノール、水
を用いて、順次分画を行ない、それぞれの可溶性画分を
得た。これらの画分の内、水飽和ブタノール画分は、こ
れを減圧蒸留して乾固させた後、水に溶かした。これを
分取HPLCでさらに分画し、活性を示す画分を得た。
この画分について分取HPLCをくり返すことにより、
精製物質(LE−V)を得た。これを凍結乾燥して、粉
末品を調製した。In the liquid-liquid solvent fraction, hexane, chloroform, ethyl acetate, water-saturated butanol and water were used as a solvent, and fractionation was carried out sequentially to obtain respective soluble fractions. Of these fractions, the water-saturated butanol fraction was distilled under reduced pressure to dryness and then dissolved in water. This was further fractionated by preparative HPLC to obtain a fraction showing activity.
By repeating preparative HPLC for this fraction,
Purified material (LE-V) was obtained. This was freeze-dried to prepare a powder product.
【0012】得られたLE−V物質について、1H N
MR分析、13C NMR分析その他の分析を行い、下記
表1に示す理化学的性質を得た。Regarding the obtained LE-V substance, 1 H N
MR analysis, 13 C NMR analysis and other analyzes were performed to obtain the physicochemical properties shown in Table 1 below.
【0013】[0013]
【表1】 [Table 1]
【0014】これらの結果から、LE−Vの構造決定を
行い、LE−Vはβ−D−グルコピラノキシ フロログ
ルシノール(β−D−glucopyranoxy phloroglucinol)
と同定された。その化学構造式は、下記化2に示すとお
りである。From these results, the structure of LE-V was determined, and LE-V was β-D-glucopyranoxy phloroglucinol.
Was identified. Its chemical structural formula is as shown in Chemical Formula 2 below.
【0015】[0015]
【化2】 Embedded image
【0016】[0016]
【実施例2】LE−V物質の虫歯及び歯周病菌に対する
抗菌活性を次のようにして測定、確認した。Example 2 The antibacterial activity of the LE-V substance against caries and periodontal disease bacteria was measured and confirmed as follows.
【0017】虫歯については、原因菌として知られるSt
reptococcus mutans ATCC 7270を用いた。歯周病につい
ては、歯肉炎と歯槽膿漏の原因菌を用いた。すなわち、
歯肉炎の原因菌としては、Prevotella intermedia及びA
ctinomyces viscosus NIAH 1010を用い、歯槽膿漏の原
因菌としては、Porphyromonas gingivalis 381を用い
た。そして、S. mutans及びA. viscosusの増殖培地とし
ては、ブレインハートインフュージョン(BHI)培地
を用い、また、P. intermedia及びP. gingivalisの増殖
培地としては、ガム(GAM)培地を用いた。Regarding tooth decay, St known as the causative fungus
reptococcus mutans ATCC 7270 was used. For periodontal disease, we used bacteria that cause gingivitis and alveolar pyorrhea. That is,
Prevotella intermedia and A are the causative bacteria of gingivitis.
Cinomyces viscosus NIAH 1010 was used, and Porphyromonas gingivalis 381 was used as the causative bacterium of alveolar pyorrhea. Brain heart infusion (BHI) medium was used as the growth medium for S. mutans and A. viscosus, and gum (GAM) medium was used as the growth medium for P. intermedia and P. gingivalis.
【0018】これら菌類に対するLE−V物質の増殖阻
害活性の測定は、濃度を変化させて添加したブイヨン培
地5mlに菌を105cells/ml接種して、37℃で2
日間培養して行った。但し、P. gingivallsについて
は、本菌が偏性嫌気性菌であるため、嫌気ジャー(BB
L製)内で培養した。その後、培養液を寒天培地に0.
1ml添加し、これを37℃、2日間培養した後、コロ
ニーの有無を観察した。To measure the growth inhibitory activity of the LE-V substance against these fungi, 10 5 cells / ml of the bacteria were inoculated into 5 ml of broth medium added at various concentrations, and the mixture was incubated at 37 ° C. for 2 hours.
It was cultured for one day. However, since P. gingivalls is an obligate anaerobic bacterium, the anaerobic jar (BB
L). Then, the culture solution was added to an agar medium at 0.
After adding 1 ml and culturing this at 37 ° C. for 2 days, the presence or absence of colonies was observed.
【0019】抗菌性は、コロニー無しの場合に滅菌と判
断した。そして、サンプル濃度と抗菌効果の相関を調
べ、活性の強さは、最小の濃度で同菌を滅菌する最小阻
害濃度(MIC)で示した。得られた結果を下記表2に
示すが、LE−Vに虫歯菌、歯周病菌に対して、卓越し
た増殖阻害効果及び滅菌効果が認められた。Antibacterial property was judged to be sterilized when there was no colony. Then, the correlation between the sample concentration and the antibacterial effect was examined, and the strength of the activity was indicated by the minimum inhibitory concentration (MIC) for sterilizing the same bacteria at the minimum concentration. The obtained results are shown in Table 2 below, and LE-V was found to have excellent growth inhibitory effect and sterilizing effect against dental caries and periodontal disease bacteria.
【0020】[0020]
【表2】 [Table 2]
【0021】[0021]
【実施例3】LE−V物質の果実貯蔵時に発生するカビ
に対する増殖阻害活性を次のようにして測定、確認し
た。Example 3 The growth inhibitory activity of the LE-V substance against the fungi generated during fruit storage was measured and confirmed as follows.
【0022】試験カビは、カビが発生した貯蔵レモン果
実から分離した。そして、緑カビ病のPenicillium digi
tatum、青カビ病のPenicillium italicumの混在した胞
子を得た。増殖培地は、ポテトデキストロース寒天(P
DA)培地を用いた。Test moulds were isolated from moldy stored lemon fruits. And Penicillium digi with green mold
Spores mixed with tatum and blue mold Penicillium italicum were obtained. The growth medium is potato dextrose agar (P
DA) medium was used.
【0023】これらカビ類に対するLE−V物質の増殖
阻害活性の測定は、LE−Vを添加した寒天培地5ml
をシャーレ(直径4.5cm)に作成し、シャーレ中心
に径2ミリの穴を開けた。そこに、105spores/ml
のカビ胞子を等量(5μl)ずつ接種して25℃、3〜
7日間培養した。生長したカビの菌糸の円径を測定し、
増殖の程度を観察した。結果を下記表3に示すが、LE
−Vにはすぐれたカビ成長抑制効果があることが確認さ
れた。The growth inhibitory activity of the LE-V substance against these molds was measured by 5 ml of an agar medium supplemented with LE-V.
Was made into a petri dish (4.5 cm in diameter), and a hole having a diameter of 2 mm was opened at the center of the petri dish. There 10 5 spores / ml
Mold fungus spores of 5 μl each at 25 ° C
Cultured for 7 days. Measure the circle diameter of the mycelium of the grown mold,
The degree of proliferation was observed. The results are shown in Table 3 below.
It was confirmed that -V has an excellent mold growth inhibitory effect.
【0024】[0024]
【表3】 [Table 3]
【0025】[0025]
【実施例4】LE−Vの微生物(細菌、酵母)に対する
抗菌性を次のようにして測定、確認した。Example 4 The antibacterial property of LE-V against microorganisms (bacteria, yeast) was measured and confirmed as follows.
【0026】細菌として、Lactobacillus casei、Strept
ococcus lactisはGAM培地で、Escherichia coli IFO
3301、Salmonella typhimurium IIP 1000、Bacillus s
ubtilis AJ 1235はNB培地で培養した。酵母として、S
accharomyces cerevisiae IFO 1346、Hansenula anomal
a IAM 12914はYM培地で培養した。各培地にLE−V
を濃度変化させて添加し、オートクレーブ処理(121
℃,15分)、各菌懸濁液を接種し、細菌は37℃で、
酵母は25℃で培養し、LE−Vの滅菌濃度を調べた。
得られた結果を下記表4に示す。As bacteria, Lactobacillus casei, Strept
ococcus lactis is Escherichia coli IFO in GAM medium
3301, Salmonella typhimurium IIP 1000, Bacillus s
ubtilis AJ 1235 was cultured in NB medium. As yeast, S
accharomyces cerevisiae IFO 1346, Hansenula anomal
a IAM 12914 was cultured in YM medium. LE-V for each medium
Was added by changing the concentration, and autoclaved (121
℃, 15 minutes), inoculate each bacterial suspension, bacteria at 37 ℃,
The yeast was cultured at 25 ° C. and the sterilization concentration of LE-V was examined.
The results obtained are shown in Table 4 below.
【0027】[0027]
【表4】 [Table 4]
【0028】[0028]
【実施例5】溶液A(LE−V50g、脱イオン水5k
g)、及び溶液B(ショ糖50g、クエン酸8g、クエ
ン酸ナトリウム8g、ビタミンC1g、香料10g、1
/5濃縮レモン果汁100g、水5kg)を用意した。Example 5 Solution A (LE-V 50 g, deionized water 5 k
g), and solution B (sucrose 50 g, citric acid 8 g, sodium citrate 8 g, vitamin C 1 g, flavor 10 g, 1
/ 5 concentrated lemon juice 100 g and water 5 kg) were prepared.
【0029】溶液A及び溶液Bをそれぞれ別々にプレー
ト殺菌機にて90〜95℃に3分間保持して殺菌した
後、5〜10℃に冷却し、タンクに貯蔵した。次いでこ
のようにして得た混合液を紙製容器に無菌的に充填し、
虫歯予防用の長期間保存可能なレモン果汁飲料を製造し
た。Solution A and solution B were separately held in a plate sterilizer at 90 to 95 ° C for 3 minutes for sterilization, then cooled to 5 to 10 ° C and stored in a tank. Then, aseptically fill the paper container with the mixed solution thus obtained,
A long-term storable lemon juice drink for preventing tooth decay was manufactured.
【0030】[0030]
【実施例6】次の配合にて、虫歯予防用歯磨を製造し
た。Example 6 A toothpaste for preventing dental caries was produced with the following formulation.
【0031】 配合(%) リン酸水素カルシウム・2水和物 45.0 グリセリン 10.0 ソルビトール 25.0 LE−V 2.0 CMC−Na 0.5 カラギーナン 0.5 サッカリン ナトリウム 0.2 ラウリル硫酸ナトリウム 1.2 ビタミンE酢酸塩 0.1 ペパーミント香料 1.0 水 残 部Formulation (%) Calcium hydrogen phosphate dihydrate 45.0 Glycerin 10.0 Sorbitol 25.0 LE-V 2.0 CMC-Na 0.5 Carrageenan 0.5 Saccharin sodium 0.2 Lauryl sulfate Sodium 1.2 Vitamin E acetate 0.1 Peppermint flavor 1.0 Water balance
【0032】[0032]
【実施例7】LE−V25.0%、グリセリン脂肪酸エ
ステル8.0%、酢酸ナトリウム4.5%、エタノール
62.5%を用いてLE−V配合製剤を調製した。Example 7 A LE-V blended preparation was prepared using LE-V 25.0%, glycerin fatty acid ester 8.0%, sodium acetate 4.5%, and ethanol 62.5%.
【0033】この配合製剤と市販のワックス製剤(甲東
社製)を2:3で混合し、LE−Vワックス製剤を調製
した。本製剤は、レモン、オレンジ、グレープフルーツ
等の柑橘類のほか、各種果実、青果物の保存にきわめて
有用であり、従来用いられている化学合成品を主体とす
るポストハーベスト農薬の代替物として、保存性はもと
より安全性の面からもきわめてすぐれたものである。This compounded formulation and a commercially available wax formulation (manufactured by Koto) were mixed at a ratio of 2: 3 to prepare an LE-V wax formulation. This formulation is extremely useful for storing citrus fruits such as lemons, oranges, and grapefruits, as well as various fruits and fruits and vegetables, and has a long shelf life as a substitute for post-harvest pesticides that are mainly chemical synthetic products that have been conventionally used. It is also extremely superior in terms of safety.
【0034】[0034]
【発明の効果】本発明に係る抗菌剤は、天然物由来であ
るため、抗菌性にすぐれているだけでなく安全性がきわ
めて高く、青果物の防カビや飲食品の抗菌に使用して非
常に有効である。また、虫歯菌、歯周病菌増殖阻害活性
も高いので、例えば、歯みがき、口中清浄剤、各種飲食
品等にも適宜調製することができる。EFFECTS OF THE INVENTION Since the antibacterial agent according to the present invention is derived from a natural product, it has not only excellent antibacterial properties but also extremely high safety, and it is very useful for preventing mildew of fruits and vegetables and antibacterial of foods and drinks. It is valid. Further, since it has a high activity of inhibiting the growth of cavities and periodontal bacteria, it can be appropriately prepared in, for example, toothpaste, mouthwash, and various foods and drinks.
【0035】また、本発明によって抗菌剤の有効成分の
構造決定もなされたので、この化合物の誘導体を製造す
ることにより、更に新規な抗菌剤の創製も期待できる。Further, since the structure of the active ingredient of the antibacterial agent was determined by the present invention, it is expected that a novel antibacterial agent will be created by producing a derivative of this compound.
Claims (5)
ラノキシ フロログルシノール(β−D−glucopyranox
y phloroglucinol)を有効成分とすることを特徴とする
抗菌剤。 【化1】 1. A β-D-glucopyranox phloroglucinol (β-D-glucopyranox) represented by the following chemical formula 1.
yphloroglucinol) as an active ingredient. Embedded image
又は抗菌剤であることを特徴とする請求項1に記載の抗
菌剤。2. An antibacterial agent and / or a shelf life improver for food and drink.
Or it is an antibacterial agent, The antibacterial agent of Claim 1 characterized by the above-mentioned.
菌剤であることを特徴とする請求項1に記載の抗菌剤。3. The antibacterial agent according to claim 1, wherein the antibacterial agent is an antibacterial agent against caries and periodontal pathogens.
る請求項1に記載の抗菌剤。4. The antibacterial agent according to claim 1, wherein the antibacterial agent is an antifungal agent.
剤であることを特徴とする請求項1に記載の抗菌剤。5. The antibacterial agent according to claim 1, wherein the antibacterial agent is an antifungal agent during storage and transportation of fruits and vegetables.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18193894A JP2901879B2 (en) | 1994-07-12 | 1994-07-12 | Antibacterial agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18193894A JP2901879B2 (en) | 1994-07-12 | 1994-07-12 | Antibacterial agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0827005A true JPH0827005A (en) | 1996-01-30 |
| JP2901879B2 JP2901879B2 (en) | 1999-06-07 |
Family
ID=16109526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18193894A Expired - Fee Related JP2901879B2 (en) | 1994-07-12 | 1994-07-12 | Antibacterial agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2901879B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005053719A3 (en) * | 2003-11-24 | 2005-09-22 | Indena Spa | Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| US12167996B2 (en) | 2018-12-05 | 2024-12-17 | Byotrol Limited | Anti-viral composition |
-
1994
- 1994-07-12 JP JP18193894A patent/JP2901879B2/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005053719A3 (en) * | 2003-11-24 | 2005-09-22 | Indena Spa | Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| JP2007512268A (en) * | 2003-11-24 | 2007-05-17 | インデナ エッセ ピ ア | Composition for treating diseases of oral cavity and upper respiratory tract |
| AU2004294688B2 (en) * | 2003-11-24 | 2010-07-22 | Indena S.P.A. | Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| US7910139B2 (en) | 2003-11-24 | 2011-03-22 | Indena S.P.A. | Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| US12167996B2 (en) | 2018-12-05 | 2024-12-17 | Byotrol Limited | Anti-viral composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2901879B2 (en) | 1999-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11596150B2 (en) | Long chain glycolipids useful to avoid perishing or microbial contamination of materials | |
| Muroi et al. | Bactericidal activity of anacardic acids against Streptococcus mutans and their potentiation | |
| JP2022001590A (en) | Anti-obesity agent, cosmetic product, and food and drink products | |
| EP3564381A1 (en) | Fermented honey product and production method therefor | |
| EP1776944A1 (en) | Antimicrobial flavor and oral care composition containing the same | |
| JP2016513631A (en) | Lactobacillus plantarum NCC2936 preparation and oral health | |
| JP3978517B2 (en) | Anti-Legionella composition | |
| KR20200129695A (en) | Fermented product of Glehnia littoralis extract, preparation method and use thereof | |
| JPWO2016043103A1 (en) | Non-pathogenic oral resident bacteria growth promoter or oral flora improving agent and oral composition | |
| JP6110240B2 (en) | Lactic acid bacteria, etc., and oral disease prevention materials and foods containing these | |
| KR101923571B1 (en) | Method for Preparing Shindari Using an Extract of Korean Dendropanax | |
| JP7445910B2 (en) | Oral compositions, oral care products, and foods containing oral resident bacteria regulators | |
| JP2996838B2 (en) | Antibacterial agent | |
| JP6744542B2 (en) | Method for culturing Lactobacillus Lactobacillus | |
| JP2901879B2 (en) | Antibacterial agent | |
| JP4669683B2 (en) | Antibacterial composition | |
| JP2018100228A (en) | Antibacterial composition, food, and method for producing cells or cell cultures or extracts thereof | |
| WO2021079921A1 (en) | Growth inhibitor for pathogenic bacteria in oral cavity, oral microflora improver, and composition for oral cavity | |
| KR102298782B1 (en) | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof | |
| JPWO2019065124A1 (en) | Oral bacterial growth inhibitory composition | |
| KR100615892B1 (en) | Natural preservatives containing mugwort extract | |
| KR101256727B1 (en) | Novel lactic acid bacteria isolated from kimchi and having antifungal activity, and compositon including it | |
| KR102904403B1 (en) | Composition having Antimicrobial Activity and Antioxidative Activity on Using an Extract or Fermentation Product of Pine Needles | |
| Han et al. | Antimicrobial Activity of Various Solvent Extracts of Auricularia auricula-judae Against Oral Bacteria. | |
| Hasibuan et al. | Development of Mouthwash Formulations based on Natural Ingredients with Antimicrobial Activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 9 Free format text: PAYMENT UNTIL: 20080319 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20090319 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20090319 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20090319 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20090319 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090319 Year of fee payment: 10 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090319 Year of fee payment: 10 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20090319 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100319 Year of fee payment: 11 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100319 Year of fee payment: 11 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20100319 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110319 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 13 Free format text: PAYMENT UNTIL: 20120319 |
|
| LAPS | Cancellation because of no payment of annual fees |